137 related articles for article (PubMed ID: 1885797)
1. FDG-PET in the selection of brain lesions for biopsy.
Hanson MW; Glantz MJ; Hoffman JM; Friedman AH; Burger PC; Schold SC; Coleman RE
J Comput Assist Tomogr; 1991; 15(5):796-801. PubMed ID: 1885797
[TBL] [Abstract][Full Text] [Related]
2. Positron emission tomography imaging-directed stereotactic neurosurgery.
Maciunas RJ; Kessler RM; Maurer C; Mandava V; Watt G; Smith G
Stereotact Funct Neurosurg; 1992; 58(1-4):134-40. PubMed ID: 1439330
[TBL] [Abstract][Full Text] [Related]
3. Combined use of 18F-fluorodeoxyglucose and 11C-methionine in 45 positron emission tomography-guided stereotactic brain biopsies.
Pirotte B; Goldman S; Massager N; David P; Wikler D; Lipszyc M; Salmon I; Brotchi J; Levivier M
J Neurosurg; 2004 Sep; 101(3):476-83. PubMed ID: 15352606
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic yield of stereotactic brain biopsy guided by positron emission tomography with [18F]fluorodeoxyglucose.
Levivier M; Goldman S; Pirotte B; Brucher JM; Balériaux D; Luxen A; Hildebrand J; Brotchi J
J Neurosurg; 1995 Mar; 82(3):445-52. PubMed ID: 7861223
[TBL] [Abstract][Full Text] [Related]
5. Regional methionine and glucose uptake in high-grade gliomas: a comparative study on PET-guided stereotactic biopsy.
Goldman S; Levivier M; Pirotte B; Brucher JM; Wikler D; Damhaut P; Dethy S; Brotchi J; Hildebrand J
J Nucl Med; 1997 Sep; 38(9):1459-62. PubMed ID: 9293808
[TBL] [Abstract][Full Text] [Related]
6. Stereotactic brain biopsy guided by positron emission tomography (PET) with [F-18]fluorodeoxyglucose and [C-11]methionine.
Pirotte B; Goldman S; David P; Wikler D; Damhaut P; Vandesteene A; Salmon L; Brotchi J; Levivier M
Acta Neurochir Suppl; 1997; 68():133-8. PubMed ID: 9233429
[TBL] [Abstract][Full Text] [Related]
7. Use of positron emission tomography (PET) in stereotactic conditions for brain biopsy.
Pirotte B; Goldman S; Bidaut LM; Luxen A; Stanus E; Brucher JM; Balériaux D; Brotchi J; Levivier M
Acta Neurochir (Wien); 1995; 134(1-2):79-82. PubMed ID: 7668134
[TBL] [Abstract][Full Text] [Related]
8. Imaging of pulmonary mass lesions with whole-body positron emission tomography and fluorodeoxyglucose.
Rege SD; Hoh CK; Glaspy JA; Aberle DR; Dahlbom M; Razavi MK; Phelps ME; Hawkins RA
Cancer; 1993 Jul; 72(1):82-90. PubMed ID: 8389668
[TBL] [Abstract][Full Text] [Related]
9. Positron emission tomography-guided stereotactic brain biopsy.
Levivier M; Goldman S; Bidaut LM; Luxen A; Stanus E; Przedborski S; Balériaux D; Hildebrand J; Brotchi J
Neurosurgery; 1992 Oct; 31(4):792-7; discussion 797. PubMed ID: 1407471
[TBL] [Abstract][Full Text] [Related]
10. PET-FDG imaging and transthoracic needle lung aspiration biopsy in evaluation of pulmonary lesions. A comparative risk-benefit analysis.
Dewan NA; Reeb SD; Gupta NC; Gobar LS; Scott WJ
Chest; 1995 Aug; 108(2):441-6. PubMed ID: 7634881
[TBL] [Abstract][Full Text] [Related]
11. First year experience using the Fischer ZD-Neurosurgical Localizing Unit with particular reference to the development of PET-guided stereotactic biopsy.
Levivier M; Goldman S; Pirotte B; Brotchi J
Acta Neurol Belg; 1993; 93(1):5-22. PubMed ID: 8451917
[TBL] [Abstract][Full Text] [Related]
12. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
13. Fluorine-18-FDG PET and iodine-123-IMT SPECT in the evaluation of brain tumors.
Weber W; Bartenstein P; Gross MW; Kinzel D; Daschner H; Feldmann HJ; Reidel G; Ziegler SI; Lumenta C; Molls M; Schwaiger M
J Nucl Med; 1997 May; 38(5):802-8. PubMed ID: 9170450
[TBL] [Abstract][Full Text] [Related]
14. Mesiobasal versus lateral temporal lobe epilepsy: metabolic differences in the temporal lobe shown by interictal 18F-FDG positron emission tomography.
Hajek M; Antonini A; Leenders KL; Wieser HG
Neurology; 1993 Jan; 43(1):79-86. PubMed ID: 8423915
[TBL] [Abstract][Full Text] [Related]
15. Work in progress: [18F] fluorodeoxyglucose and positron emission tomography in the evaluation of radiation necrosis of the brain.
Patronas NJ; Di Chiro G; Brooks RA; DeLaPaz RL; Kornblith PL; Smith BH; Rizzoli HV; Kessler RM; Manning RG; Channing M; Wolf AP; O'Connor CM
Radiology; 1982 Sep; 144(4):885-9. PubMed ID: 6981123
[TBL] [Abstract][Full Text] [Related]
16. Differentiation of recurrent astrocytoma from radiation necrosis: a pilot study with 13N-NH3 PET.
Xiangsong Z; Weian C
J Neurooncol; 2007 May; 82(3):305-11. PubMed ID: 17120157
[TBL] [Abstract][Full Text] [Related]
17. PET-FDG of pleomorphic xanthoastrocytoma.
Bicik I; Raman R; Knightly JJ; Di Chiro G; Fulham MJ
J Nucl Med; 1995 Jan; 36(1):97-9. PubMed ID: 7799091
[TBL] [Abstract][Full Text] [Related]
18. Cancer detection with whole-body PET using 2-[18F]fluoro-2-deoxy-D-glucose.
Hoh CK; Hawkins RA; Glaspy JA; Dahlbom M; Tse NY; Hoffman EJ; Schiepers C; Choi Y; Rege S; Nitzsche E
J Comput Assist Tomogr; 1993; 17(4):582-9. PubMed ID: 8331230
[TBL] [Abstract][Full Text] [Related]
19. Identification of early recurrence of primary central nervous system tumors by [18F]fluorodeoxyglucose positron emission tomography.
Glantz MJ; Hoffman JM; Coleman RE; Friedman AH; Hanson MW; Burger PC; Herndon JE; Meisler WJ; Schold SC
Ann Neurol; 1991 Apr; 29(4):347-55. PubMed ID: 1929205
[TBL] [Abstract][Full Text] [Related]
20. [Metabolic imaging to follow stereotactic radiation of gliomas -- the role of 1H MR spectroscopy in comparison to FDG-PET and IMT-SPECT].
Lichy MP; Henze M; Plathow C; Bachert P; Kauczor HU; Schlemmer HP
Rofo; 2004 Aug; 176(8):1114-21. PubMed ID: 15346287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
